Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lead time estimation in a controlled screening program.

J S Chen, P C Prorok

    American Journal of Epidemiology
    |November 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A large chest wall tumour in an asymptomatic 15-year-old girl.

    BMJ case reports·2011
    Same author

    Nanogranular L1(0) FePt-C-Ta2O5 composite media for perpendicular recording applications.

    Journal of nanoscience and nanotechnology·2011
    Same author

    Interlayer exchange coupling effect of L1(0) CoPt based exchange coupled composite media.

    Journal of nanoscience and nanotechnology·2011
    Same author

    NiW/Ru underlayer for CoPt-SiO2 granular perpendicular recording media.

    Journal of nanoscience and nanotechnology·2011
    Same author

    Nanostructured SmCo5 thin films with perpendicular anisotropy formed in a wide range of Sm-Co compositions.

    Journal of nanoscience and nanotechnology·2011
    Same author

    Endoscopic evolution of rectal stercoral ulcer presenting with a large bleeding pseudodiverticulum in a patient with chronic constipation.

    Endoscopy·2011
    Same journal

    Correction to: Home dampness and molds and occurrence of respiratory tract infections in the first 27 years of life: the Espoo Cohort Study.

    American journal of epidemiology·2026
    Same journal

    A SIMPLE AND POWERFUL TEST OF VACCINE WANING.

    American journal of epidemiology·2026
    Same journal

    Association Between maternal body mass index, offspring growth and pubertal timing: results from a longitudinal birth cohort study.

    American journal of epidemiology·2026
    Same journal

    Correction to: Developing a novel algorithm to identify incident and prevalent dementia in Medicare claims-the ARIC Study.

    American journal of epidemiology·2026
    Same journal

    RE: advancing observational research on arts and health: theory-informed approaches using the RADIANCE framework.

    American journal of epidemiology·2026
    Same journal

    Maternal Cesarean Section and Offspring ASD or ADHD Risk: A Nurses' Health Study II Analysis.

    American journal of epidemiology·2026
    See all related articles

    This study introduces a new method to estimate disease lead time distribution from single-shot screening programs. It uses a three-state disease model and compares incidence rates between screened and control groups, avoiding assumptions about false negatives.

    Area of Science:

    • Epidemiology
    • Biostatistics
    • Medical Screening

    Background:

    • Estimating the lead time distribution of diseases detected via screening is crucial for evaluating program effectiveness.
    • Previous methods often require assumptions about the screening test's false negative rate or the preclinical disease duration.
    • A robust method is needed that accommodates the complexities of disease progression and screening interventions.

    Purpose of the Study:

    • To develop and present a novel method for estimating the discrete lead time distribution of disease cases identified in single-shot screening programs.
    • To provide a flexible estimation procedure that does not necessitate prior assumptions regarding the false negative rate of the screening test or the distribution of preclinical state duration.

    Main Methods:

    • The proposed method utilizes a three-state progressive disease model encompassing natural disease history and screening.

    Related Experiment Videos

  • Key parameters include age at entry into the preclinical state, preclinical state duration, and age at screening/observation.
  • Estimation is achieved by comparing observed disease incidence rates between a screened cohort and a randomized control group over successive follow-up intervals post-screening.

    • Main Results:

    • The method successfully estimates the discrete lead time distribution without requiring assumptions on false negative rates.
    • It effectively models disease progression and screening impact using a comparative incidence rate approach.
    • The procedure is demonstrated using breast cancer screening data, showcasing its practical applicability.

    Conclusions:

    • The presented method offers a valuable tool for quantifying disease lead time in single-shot screening contexts.
    • It enhances the ability to evaluate screening program performance by providing a more flexible and assumption-free estimation technique.
    • This approach has significant implications for public health research and the optimization of cancer screening strategies.